DNAzyme Biosensor for Rapid Staphylococcus aureus Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting Staphylococcus aureus, including plate culturing and rapid tests, face challenges such as lengthy results, extensive sample processing, poor sensitivity, and specificity issues, particularly in resource-limited settings and for methicillin-resistant strains.
Innovation Solution
A simple fluorogenic or colorimetric biosensor system utilizing an RNA-cleaving DNAzyme activated by Staphylococcus aureus, which provides rapid and sensitive detection in nasal mucus with minimal processing, using a catalytic nucleic acid probe immobilized on a solid support within a lateral flow biosensor system.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If classical plate culturing methods are used for detecting Staphylococcus aureus, then detection accuracy and sensitivity are improved, but result time increases to up to 2 days
Solution Approach 1:
The patent replaces the mechanical/cultural detection system with a molecular-based detection system using DNAzymes that catalyze fluorescent reactions. This substitution enables rapid detection within minutes while maintaining high accuracy, directly resolving the time-accuracy tradeoff in bacterial detection.
Solution Approach 2:
The patent changes the detection parameter from colonial growth visualization to fluorescent signal generation. By using DNAzymes that produce fluorescent signals upon binding to bacterial targets, the system achieves both rapid results (minutes) and high detection accuracy, eliminating the 2-day waiting period of traditional methods.
2Loss of time
If rapid detection techniques such as PCR and ELISA are used, then result time is reduced to under 1 hour, but device complexity and sample processing requirements increase
Solution Approach 1:
The patent extracts and simplifies the detection mechanism to a single-step binding reaction between DNAzymes and bacterial targets. By removing complex amplification steps (PCR) or multiple reagent layers (ELISA), the system achieves rapid results in under 1 hour with minimal sample processing, directly reducing device complexity while maintaining speed.
Solution Approach 2:
The DNAzyme-based system performs detection through autonomous binding and fluorescent signal generation without requiring external amplification machinery or complex sample preparation. The DNAzymes self-assemble with targets and produce signals intrinsically, eliminating the need for complex equipment and procedures while maintaining rapid detection capability.
3Loss of time
If rapid lateral flow tests are used for Staphylococcus aureus detection, then result time is reduced to under 1 hour, but sensitivity and specificity deteriorate
Solution Approach 1:
The patent changes the detection parameter from simple agglutination or color change to fluorescent signal generation. This parameter change enables the system to achieve both rapid results (under 1 hour) and high sensitivity, as the fluorescent DNAzyme-bacterial complex provides a robust, quantifiable signal that overcomes the sensitivity limitations of traditional lateral flow methods.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables rapid, specific, and sensitive detection of Staphylococcus aureus in minutes with minimal sample processing, maintaining functionality for at least six months when stored desiccated, and is suitable for point-of-care use in various settings.
Implementation Method 1
a first nucleic acid region that (i) is capable of binding to a microorganism target, and (ii) has catalytic activity for cleaving a substrate, optionally a detectable substrate
Implementation Method 2
a first nucleic acid region that (i) is capable of binding to a microorganism target
Implementation Method 3
A simple fluorogenic or colorimetric biosensor system utilizing an RNA-cleaving DNAzyme
Data Source
AI summary
This disclosure relates to catalytic nucleic acid probes, biosensors and lateral flow biosensor systems and methods and kits of using the probes, biosensors and lateral flow biosensor systems for detecting microorganisms such as Staphylococcus aureus.